DE60106974D1 - Aminotriazolopyridinderivate als adenosinrezeptorliganden - Google Patents

Aminotriazolopyridinderivate als adenosinrezeptorliganden

Info

Publication number
DE60106974D1
DE60106974D1 DE60106974T DE60106974T DE60106974D1 DE 60106974 D1 DE60106974 D1 DE 60106974D1 DE 60106974 T DE60106974 T DE 60106974T DE 60106974 T DE60106974 T DE 60106974T DE 60106974 D1 DE60106974 D1 DE 60106974D1
Authority
DE
Germany
Prior art keywords
aminotriazolopyridine
derivatives
receptor ligands
adenosine receptor
adenosine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60106974T
Other languages
English (en)
Other versions
DE60106974T2 (de
Inventor
Bernd Brodbeck
Matthias Heinrich Nettekoven
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE60106974D1 publication Critical patent/DE60106974D1/de
Application granted granted Critical
Publication of DE60106974T2 publication Critical patent/DE60106974T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Addiction (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE60106974T 2000-12-15 2001-12-07 Aminotriazolopyridinderivate als adenosinrezeptorliganden Expired - Lifetime DE60106974T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00127567 2000-12-15
EP00127567 2000-12-15
PCT/EP2001/014399 WO2002048145A1 (en) 2000-12-15 2001-12-07 Aminotriazolopyridiine derivatives as adenosine receptor ligands

Publications (2)

Publication Number Publication Date
DE60106974D1 true DE60106974D1 (de) 2004-12-09
DE60106974T2 DE60106974T2 (de) 2005-11-03

Family

ID=8170683

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60106974T Expired - Lifetime DE60106974T2 (de) 2000-12-15 2001-12-07 Aminotriazolopyridinderivate als adenosinrezeptorliganden

Country Status (21)

Country Link
US (1) US6506772B1 (de)
EP (1) EP1347974B1 (de)
JP (1) JP4049672B2 (de)
KR (1) KR100540628B1 (de)
CN (1) CN1221551C (de)
AR (1) AR031799A1 (de)
AT (1) ATE281456T1 (de)
AU (2) AU3167402A (de)
BR (1) BR0116193A (de)
CA (1) CA2437006C (de)
DE (1) DE60106974T2 (de)
DK (1) DK1347974T3 (de)
ES (1) ES2230387T3 (de)
GT (1) GT200100253A (de)
MX (1) MXPA03005334A (de)
PA (1) PA8534701A1 (de)
PE (1) PE20020666A1 (de)
PT (1) PT1347974E (de)
UY (1) UY27074A1 (de)
WO (1) WO2002048145A1 (de)
ZA (1) ZA200304481B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1435952A1 (de) * 2001-10-08 2004-07-14 F. Hoffmann-La Roche Ag 8-amino-(1,2,4)triazolo(1,5-a)pyridin-6-carbonsäureamid
EP1556053A4 (de) * 2002-10-31 2006-04-19 Amgen Inc Entzündungshemmende mittel
CA2573271C (en) 2004-07-15 2015-10-06 Amr Technology, Inc. Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
AU2007272009A1 (en) * 2006-07-12 2008-01-17 Syngenta Limited Triazolopyridine derivatives as herbicides
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
WO2010132437A1 (en) * 2009-05-12 2010-11-18 Albany Molecular Research, Inc. Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
KR20120023072A (ko) 2009-05-12 2012-03-12 브리스톨-마이어스 스큅 컴퍼니 （Ｓ）-7-（〔1,2,4〕트리아졸〔1,5-ａ〕피리딘-6-일）-4-（3,4-디클로로페닐）-1,2,3,4-테트라하이드로이소퀴놀린의 결정형 및 이의 용도
AU2010247763B2 (en) * 2009-05-12 2015-12-24 Albany Molecular Research, Inc. 7-([1,2,4,]triazolo[1,5,-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4- tetrahydroisoquinoline and use thereof
WO2013043520A1 (en) * 2011-09-22 2013-03-28 Merck Sharp & Dohme Corp. Triazolopyridyl compounds as aldosterone synthase inhibitors
US20140235667A1 (en) 2011-09-22 2014-08-21 Merck Sharp & Dohme Corp. Imidazopyridyl compounds as aldosterone synthase inhibitors
JP7399589B2 (ja) * 2018-09-12 2023-12-18 日本化薬株式会社 有害生物防除剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356894A (en) 1990-05-29 1994-10-18 Rodney Peter W Morpholinyl substituted [1,2,4]-triazolo[1,5-a]triazine as antagonist
GB9226735D0 (en) 1992-12-22 1993-02-17 Ici Plc Azole derivatives
AU2639299A (en) 1998-02-24 1999-09-15 Kyowa Hakko Kogyo Co. Ltd. Remedies/preventives for parkinson's disease
US6355653B1 (en) 1999-09-06 2002-03-12 Hoffmann-La Roche Inc. Amino-triazolopyridine derivatives

Also Published As

Publication number Publication date
CN1221551C (zh) 2005-10-05
ATE281456T1 (de) 2004-11-15
AU3167402A (en) 2002-06-24
UY27074A1 (es) 2002-07-31
AR031799A1 (es) 2003-10-01
CA2437006A1 (en) 2002-06-20
DE60106974T2 (de) 2005-11-03
AU2002231674B2 (en) 2006-07-06
JP2004521096A (ja) 2004-07-15
US6506772B1 (en) 2003-01-14
EP1347974B1 (de) 2004-11-03
KR20030061446A (ko) 2003-07-18
CN1486314A (zh) 2004-03-31
PE20020666A1 (es) 2002-07-27
DK1347974T3 (da) 2005-03-14
MXPA03005334A (es) 2004-04-02
PT1347974E (pt) 2005-02-28
ES2230387T3 (es) 2005-05-01
PA8534701A1 (es) 2002-08-26
KR100540628B1 (ko) 2006-01-11
JP4049672B2 (ja) 2008-02-20
EP1347974A1 (de) 2003-10-01
GT200100253A (es) 2002-07-31
WO2002048145A1 (en) 2002-06-20
ZA200304481B (en) 2004-09-09
CA2437006C (en) 2009-10-27
BR0116193A (pt) 2003-09-23

Similar Documents

Publication Publication Date Title
ATE253067T1 (de) Diazabicyloderivate als nikotin-acetylcholin- rezeptorliganden
CY2011002I1 (el) N-πυρραζολικοι αγωνιστες του α2α υποδοχεα
DOP2001000220A (es) Derivados de imidazol
ATE372988T1 (de) Pyrimidin-derivate
ATE293618T1 (de) 4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel
ATE360620T1 (de) Imidazolderivate
PT1303521E (pt) Derivados de tetra-hidro-heterocicloazepinil-pirimidina
PL373953A1 (en) 7-amino-benzothiazole derivatives as adenosine receptor ligands
ATE306265T1 (de) Benzothiazolderivate als adenosin-rezeptor- liganden
DE60114852D1 (de) Chinazolin-derivate als alpha-1 adrenerge antagonisten
DE60137061D1 (de) Platin-verbindungen als antitumorwirkstoffe
ATE414056T1 (de) Substituierte c-cyclohexylmethylamin-derivative
AR028602A1 (es) Derivados de pirrol
AR028282A1 (es) Derivados de aminofenil pirimidona
DE60106974D1 (de) Aminotriazolopyridinderivate als adenosinrezeptorliganden
DE60305058D1 (de) Imidazoquinoline derivate als adenosine a3 rezeptor liganden
ATE293619T1 (de) Pyridinderivate als nmda-rezeptorliganden
IL162444A (en) Triazolo-quinolin derivatives useful as adenosine receptor ligands
DE60003072D1 (de) Thiazolidindion-derivate als antidiabetika
DE50103035D1 (de) Substituierte 1-aminobutan-3-ol-derivate
ATE282021T1 (de) Substituierte aminomethyl-phenyl- cyclohexanderivate
ATE338043T1 (de) 5-methoxy-8-aryl- 1,2,4ötriazolo 1,5-aöpyridine derivative als adenosin-rezeptor antagonisten
PT1246791E (pt) Derivados de aminometilfenilciclo-hexanona
DE60012953D1 (de) 3-amino-2-phenylpiperidinderivate als substanz p antagonisten
DE50112454D1 (de) Substituierte 5-amino-1-penten-3-ol-derivate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition